Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
AJNR Am J Neuroradiol ; 43(8): 1196-1201, 2022 08.
Article de Anglais | MEDLINE | ID: mdl-35863783

RÉSUMÉ

BACKGROUND AND PURPOSE: The prognosis and treatment of pediatric low-grade gliomas is influenced by their molecular subtype. MR imaging remains the mainstay for initial work-up and surgical planning. We aimed to determine the relationship between imaging patterns and molecular subtypes of pediatric low-grade gliomas. MATERIALS AND METHODS: This was a retrospective bi-institutional study for patients diagnosed from 2004 to 2021 with pathologically confirmed pediatric low-grade gliomas molecularly defined as BRAF fusion, BRAF V600E mutant, or wild-type (which is neither BRAF V600E mutant nor BRAF fusion). Two neuroradiologists, blinded, independently reviewed imaging parameters from diagnostic MRIs, and discrepancies were resolved by consensus. Bivariate analysis was used followed by pair-wise comparison of the Dwass-Steel-Critchlow-Fligner method to compare the 3 molecular subtypes. Interreader agreement was assessed using κ. RESULTS: We included 70 patients: 30 BRAF fusion, 19 BRAF V600E mutant, and 21 wild-type. There was substantial agreement between the readers for overall imaging variables (κ = 0.75). BRAF fusion tumors compared with BRAF V600E and wild-type tumors were larger (P = .0022), and had a greater mass effect (P = .0053), increased frequency of hydrocephalus (P = .0002), and diffuse enhancement (p <.0001). BRAF V600E mutant tumors were more often hemispheric (P < .0001), appeared more infiltrative (P = .0002), and, though infrequent, were the only group demonstrating diffusion restriction (qualitatively; P = .0042) with a lower ADC ratio (quantitatively) (P = .003). CONCLUSIONS: BRAF fusion and BRAF V600E mutant pediatric low-grade gliomas have unique imaging features that can be used to differentiate them from each other and wild-type pediatric low-grade glioma using a standard radiology review with high interreader agreement. In the era of targeted therapy, these features can be useful for therapeutic planning before surgery.


Sujet(s)
Tumeurs du cerveau , Gliome , Enfant , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/génétique , Tumeurs du cerveau/anatomopathologie , Gliome/imagerie diagnostique , Gliome/génétique , Gliome/anatomopathologie , Imagerie par résonance magnétique , Mutation , Neurofibromatose de type 1/complications , Protéines proto-oncogènes B-raf/génétique , Études rétrospectives
4.
Anaesthesist ; 62(2): 130-6, 2013 Feb.
Article de Allemand | MEDLINE | ID: mdl-23344644

RÉSUMÉ

In the medical treatment of children drugs are frequently used outside the boundaries of the approved licensing and use under the terms of off-label use is possible. However, this requires critical reasoning and experience with the drug involved. With help of a traffic light colored spreadsheet this article illustrates the limitations, problems and possibilities of pharmacotherapy in pediatric emergencies or pediatric anesthesia. Of the 45 emergency drugs listed in this article most can be used in childhood, at least under specific conditions. Licensing restrictions occur especially in the newborn period and infancy resulting in frequent off-label use. Severe pitfalls, such as the propofol infusion syndrome after long-term sedation with propofol under the age of 16 years, emphasize the need for serious reflection on the substances involved. Decisions regarding pharmaceutical therapy should be based on the current standard of medical knowledge. When official recommendations from pharmaceutical companies are missing, treatment decisions for off-label use can be based on guidelines, study and literature databases or recommendations in medical journals.


Sujet(s)
Services des urgences médicales/méthodes , Utilisation hors indication , Pédiatrie/méthodes , Enfant , Enfant d'âge préscolaire , Sédation consciente , Agrément de médicaments , Services des urgences médicales/législation et jurisprudence , Recommandations comme sujet , Humains , Nouveau-né , Utilisation hors indication/législation et jurisprudence , Pédiatrie/législation et jurisprudence , Pharmacocinétique
5.
Anaesthesist ; 61(11): 965-70, 2012 Nov.
Article de Allemand | MEDLINE | ID: mdl-23135772

RÉSUMÉ

Life-threatening pediatric emergencies are rare events in which precise, correct and fast drug dosing is essential. Intravenous drugs are most commonly dosed based on the child's weight in mg/kg. Numerous tools exist for aiding the physician in the error prone calculation, none of which meet all criteria for the perfect tool. Besides frequent training of practical skills and awareness of the problem of calculating the exact drug dose, it seems indispensable to have a localized tool at hand for these critical events.


Sujet(s)
Services des urgences médicales/méthodes , Préparations pharmaceutiques/administration et posologie , Taille/physiologie , Poids/physiologie , Enfant , Compétence clinique , Traitement médicamenteux/normes , Humains , Injections veineuses , Erreurs médicales , Systèmes de distribution des médicaments
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...